See other companies on Welcome to the Jungle

FabricNano

Biomanufacturing approach to producing chemicals

FabricNano logo
21-100 employees
  • B2B
  • Manufacturing
  • Biology
  • Environmental
  • Science
London, UK

Company mission

FabricNanos's mission is to replace all fermented and petrochemical products in the world with biomanufactured alternatives.

Top investors

Our take

Harvesting the power of single-cell organisms is one of humankind’s oldest manufacturing techniques: Think of beer, wine, cheese, and bread. FabricNano is invested in the creation of cell-free biomanufacturing. Biomanufacturing is the use of enzymes within a cell or microbe to produce an end-product. Those enzymes, can produce chemicals, like those used to make drugs or plastics, with higher efficiency compared to cell-based systems, and without the reliance on fossil fuels that are currently used to make those chemicals en masse.

Building a business within the ‘golden triangle’ of Oxford, Cambridge, and London, FabricNano has convened an interdisciplinary team by drawing from experts across biochemistry, chemistry, enzymology, computer science and theoretical physics.

The biggest limitation to FabricNano’s success may be finding a reliable and inexpensive source of the enzymes used in the chemical reaction. In living organisms, most of the enzymes are produced by the cells themselves, or the organism ingests them from the environment. In FabricNano’s case, the enzymes must be manufactured in-house or purchased.

Freddie headshot

Freddie

Company Specialist at Welcome to the Jungle

Company values

  • Always choose candor
  • Be curious about each other's work
  • Busy doesn't count; results do
  • If you aren't thriving, your work isn't thriving
  • This is your business

Funding (last 2 of 3 rounds)

May 2021

$11m

SERIES A

Dec 2020

$0.6m

GRANT

Total funding: $14.2m

This company has top investors

Leadership

Former Research Analyst at the Federal Reserve Bank of New York with a Master of Research in Economics from the London Business School.

Computational biophysicist with a PhD in DNA theoretical biophysics.